Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tove Holst Filtenborg Tvedskov

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|April 12, 2026
Management of non-detection of the sentinel node in breast cancer: A scoping reviewLærke Smedegaard Andersen, Katrine Jensen, Tove Holst Filtenborg Tvedskov
Ugeskrift for Laeger|March 27, 2024
Hoda Khorasani, Tove Holst Filtenborg Tvedskov, Tine Engberg Damsgaard
Clinical Breast Cancer|August 29, 2024
Evaluating the Prognostic Role of the PAM50 Signature and Selected Immune-Related Signatures for Recurrence in Patients With T1abN0 Breast CancerChristina M S Hassing, Tove Holst Filtenborg Tvedskov, Niels Kroman, et al.
Breast Cancer Research and Treatment|December 28, 2022
Adjuvant chemotherapy in patients with ER-negative/HER2-negative, T1abN0 breast cancer: a nationwide studyChristina M S Hassing, Mathias Kvist Mejdahl, Anne-Vibeke Lænkholm, et al.
Breast Cancer Research and Treatment|September 8, 2022
Benefit of adjuvant chemotherapy and trastuzumab in patients with HER2-positive, node-negative breast tumors ≤ 10 mm: a nationwide studyChristina M S Hassing, Mathias Kvist Mejdahl, Anne-Vibeke Lænkholm, et al.
Critical Reviews in Oncology/Hematology|February 28, 2023
Adjuvant treatment with trastuzumab of patients with HER2-positive, T1a-bN0M0 breast tumors: A systematic review and meta-analysisChristina M S Hassing, Dorte Lisbet Nielsen, Ann Søegaard Knoop, et al.
Critical Reviews in Oncology/Hematology|February 21, 2026
Benefit of adjuvant chemotherapy in patients with T1a-bN0, triple-negative breast cancer - a systematic review and meta-analysisChristina M S Hassing, Carsten Bogh Juhl, Tove Holst Filtenborg Tvedskov, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|April 12, 2026
Management of non-detection of the sentinel node in breast cancer: A scoping reviewLærke Smedegaard Andersen, Katrine Jensen, Tove Holst Filtenborg Tvedskov
Ugeskrift for Laeger|March 27, 2024
Hoda Khorasani, Tove Holst Filtenborg Tvedskov, Tine Engberg Damsgaard
Clinical Breast Cancer|August 29, 2024
Evaluating the Prognostic Role of the PAM50 Signature and Selected Immune-Related Signatures for Recurrence in Patients With T1abN0 Breast CancerChristina M S Hassing, Tove Holst Filtenborg Tvedskov, Niels Kroman, et al.
Breast Cancer Research and Treatment|December 28, 2022
Adjuvant chemotherapy in patients with ER-negative/HER2-negative, T1abN0 breast cancer: a nationwide studyChristina M S Hassing, Mathias Kvist Mejdahl, Anne-Vibeke Lænkholm, et al.
Breast Cancer Research and Treatment|September 8, 2022
Benefit of adjuvant chemotherapy and trastuzumab in patients with HER2-positive, node-negative breast tumors ≤ 10 mm: a nationwide studyChristina M S Hassing, Mathias Kvist Mejdahl, Anne-Vibeke Lænkholm, et al.
Critical Reviews in Oncology/Hematology|February 28, 2023
Adjuvant treatment with trastuzumab of patients with HER2-positive, T1a-bN0M0 breast tumors: A systematic review and meta-analysisChristina M S Hassing, Dorte Lisbet Nielsen, Ann Søegaard Knoop, et al.
Critical Reviews in Oncology/Hematology|February 21, 2026
Benefit of adjuvant chemotherapy in patients with T1a-bN0, triple-negative breast cancer - a systematic review and meta-analysisChristina M S Hassing, Carsten Bogh Juhl, Tove Holst Filtenborg Tvedskov, et al.
Pageof 1